Tanonalla

Tanonalla combines oxycodone hydrochloride and naloxone hydrochloride dihydrate for oral use, designed to support pain relief while managing opioid-induced constipation. This dual-action formulation is commonly prescribed for moderate to severe pain under medical supervision. Suitable for adults requiring around-the-clock analgesia. Short-term use recommended as directed.

Tanonalla is used to relieve moderate to severe pain when continuous opioid therapy is needed. The inclusion of naloxone helps counteract constipation often associated with long-term opioid use. It is prescribed for patients who have not responded adequately to non-opioid pain relievers. Always follow healthcare provider instructions for appropriate use.

This medication may produce drowsiness, dizziness, or mild nausea, especially when first starting treatment. Some users report dry mouth or headache as common effects. These responses typically lessen as the body adjusts to the medication. Staying hydrated and moving slowly when standing can help manage these effects.

Keep Tanonalla in a secure, child-resistant container away from moisture and heat. Avoid alcohol and other sedating substances while taking this medication. Do not crush, break, or chew the tablets unless advised by a healthcare professional. Store at room temperature and dispose of unused medication properly.

Tanonalla may interact with alcohol, benzodiazepines, or other central nervous system depressants, increasing sedation risk. CYP3A4 inhibitors like certain antifungals or macrolide antibiotics can increase oxycodone levels. CYP3A4 inducers such as rifampin may reduce its effectiveness. Always inform your healthcare provider about all medications being taken.